Boundless Bio, Inc.
General ticker "BOLD" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $35.1M (TTM average)
Boundless Bio, Inc. does not follow the US Stock Market performance with the rate: -4.8%.
Estimated limits based on current volatility of 2.9%: low 1.22$, high 1.29$
Factors to consider:
- Total employees count: 200000 as of 2024
Short-term BOLD quotes
Long-term BOLD plot
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $46.47MM | $54.80MM | $73.27MM |
| Operating Income | $-46.47MM | $-54.80MM | $-73.27MM |
| Non-Operating Income | $0.57MM | $5.36MM | $7.90MM |
| R&D Expense | $37.16MM | $42.64MM | $55.27MM |
| Income(Loss) | $-45.90MM | $-49.43MM | $-65.36MM |
| Profit(Loss)* | $-45.90MM | $-49.43MM | $-65.36MM |
| Stockholders Equity | $-81.70MM | $-127.08MM | $150.64MM |
| Assets | $76.83MM | $129.89MM | $206.41MM |
| Operating Cash Flow | $-39.60MM | $-46.85MM | $-60.84MM |
| Capital expenditure | $1.07MM | $0.63MM | $2.54MM |
| Investing Cash Flow | $16.13MM | $-38.26MM | $-26.10MM |
| Financing Cash Flow | $0.13MM | $97.90MM | $89.82MM |
| Earnings Per Share** | $-2.06 | $-2.22 | $-3.85 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.